BCAAs, Muscle Protein Synthesis and Glucose Uptake
Launched by WAGENINGEN UNIVERSITY · Jan 11, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of amino acids in a drink affect how well our bodies use insulin and build muscle. Specifically, the researchers want to see the differences between a drink that contains all amino acids and one that is missing branched-chain amino acids (BCAAs), which are important for muscle health. The goal is to understand how these drinks can influence muscle growth and the body’s ability to take in glucose, which is a type of sugar that provides energy.
To participate in this study, you should be between 18 and 35 years old, have a healthy weight (not too underweight or overweight), and engage in regular physical activity at least once a week. However, certain conditions will exclude you, such as smoking, diabetes, heart disease, or any serious health issues. If you join the trial, you will consume one of the test drinks and help researchers gather important information about muscle and insulin response. The study is currently looking for participants, so if you fit the eligibility criteria and are interested, this could be a great opportunity!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged from 18-35 years
- • 18.5 \< Body mass index \< 30 kg·m2
- • Recreationally active (performing non-competitive physical exercise at least one time per week for minimally 30 minutes)
- Exclusion Criteria:
- • Smoking
- • Diabetes (Type 1, Type 2, or genetic form of diabetes)
- • Any diagnosed cardiovascular (heart) disease or high blood pressure (≥140 mmHg systolic and/or ≥90 mmHg diastolic)
- • Chronic use of any prescribed or over the counter pharmaceuticals (excluding oral contraceptives and contraceptive devices)
- • Known allergy to lidocaine
- • Regular use of dietary protein and/or amino acid supplements (\>3 times per week)
- • Currently involved in a structured progressive resistance training programme (\>3 times per week)
- • A personal or family history of thrombosis (clots), epilepsy, seizures, or schizophrenia.
- • Any previous motor disorders or disorders in muscle and/or lipid metabolism
- • Presence of an ulcer in the stomach or gut and/or strong history of indigestion
- • Known severe kidney problems
- • Pregnant or breastfeeding
- • Unable to give consent
About Wageningen University
Wageningen University, a leading institution in the fields of life sciences and agricultural research, is dedicated to advancing knowledge and innovation through robust clinical trials. Renowned for its interdisciplinary approach, the university leverages cutting-edge research methodologies and state-of-the-art facilities to explore critical health and environmental challenges. With a commitment to sustainability and public health, Wageningen University collaborates with various stakeholders to conduct trials that aim to improve health outcomes and promote evidence-based practices in both clinical and community settings. Through its rigorous scientific framework, the university strives to contribute valuable insights that inform policy and enhance overall quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wageningen, Gelderland, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported